+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Neurorehabilitation Device Market 2019-2028

  • ID: 5187989
  • Report
  • November 2020
  • Region: Asia Pacific
  • 130 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bionik Laboratories Corp
  • Ectron Limited
  • Hokoma Ag
  • Kinova
  • Neurostyle Pte Ltd
  • MORE
MARKET OUTLOOK

The Asia-Pacific neurorehabilitation devices market is progressing at a CAGR of 15.04% and is expected to advance even further in the forecasting phase from 2019 to 2028. India, South Korea, China, Japan, Australia & New Zealand, ASEAN countries and Rest of Asia-Pacific for the market in this region.

The neurorehabilitation device market in India is driven primarily by the rising prevalence of stroke, along with the initiatives taken by the state governments and encouragement from foreign private organizations present in the nation. According to the WHO, the rate of prevalence of stroke in the Indian population accounts for 58 per 100000 people. Further, people above 55 years of age are more prone to be affected by stroke. This is fueling the demand and adoption of neurorehabilitation devices in the country.

Estimates from the World Health Organization (WHO) suggest that 80000 individuals in Australia are diagnosed by Parkinson’s disease every year, with 32 cases being diagnosed every day. Further, according to the WHO, around 10% of the individuals are diagnosed with this condition before they reach 40 years of age. The need to diagnose and treat such diseases is fueling the demand for neurorehabilitation devices, thus benefiting the studied market in the country. Australia’s Health Ministry announced in 2017, that it would invest around $40 million for medical projects to research further on dementia. This move has paved the way for the growth of the Australian neurorehabilitation device market.

COMPETITIVE OUTLOOK

The prime companies dominating this market are Bionik Laboratories Corp, Helius Medical Technologies, Kinova, Kinestica, Tyromotion GmbH, Biometrics Ltd, Neurostyle Pte Ltd, and Saebo.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bionik Laboratories Corp
  • Ectron Limited
  • Hokoma Ag
  • Kinova
  • Neurostyle Pte Ltd
  • MORE
1. Asia-Pacific Neurorehabilitation Device Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Supply Chain Outlook
2.4. Impact of Coronavirus on Neurorehabilitation Device Market
2.5. Etymology of Neurorehabilitation Device
2.6. Key Impact Analysis
2.7. Market Attractiveness Index
2.8. Key Insights
2.9. Market Drivers
2.9.1. Rise in Geriatric Population
2.9.2. Growing Emergence of Neurorehabilitation Wearables and Robotics
2.9.3. Rising Prevalence of Neurological Diseases
2.10. Market Restraints
2.10.1. Lack of Skilled Workforce to Treat and Manage Neurological Diseases
2.10.2. High Cost of Treatment
2.11. Market Opportunities
2.11.1. Advancements in Technology
2.11.2. Rising Incidence of Neurological Disorders in Developing Economies
2.12. Market Challenges
2.12.1. Stringent Government Regulations

3. Neurehabilitation Device Market Outlook - by Product
3.1. Neuro-Robotic System
3.2. Brain-Computer Interface
3.3. Wearable Device
3.4. Non-Invasive Stimulator
3.5. Other Products

4. Neurehabilitation Device Market Outlook - by Application
4.1. Stroke
4.2. Cerebral Palsy
4.3. Parkinson's Disease
4.4. Multiple Sclerosis
4.5. Other Applications

5. Neurehabilitation Device Market Outlook - by End-User
5.1. Hospital/Clinic
5.2. Research Institute
5.3. Cognitive Care Center
5.4. Other End-User

6. Neurehabilitation Device Market - Asia-Pacific
6.1. Country Analysis
6.1.1. China
6.1.2. Japan
6.1.3. Australia & New Zealand
6.1.4. India
6.1.5. South Korea
6.1.6. Asean Countries
6.1.7. Rest of APAC

7. Company Profiles
7.1. Bionik Laboratories Corp
7.2. Tyromotion Gmbh
7.3. Bioxtreme
7.4. Ectron Limited
7.5. Kinova
7.6. Abbott Laboratories
7.7. Biometrics Ltd
7.8. Reha Technology Ag
7.9. Medtronic Inc
7.10. Helius Medical Technologies
7.11. Hokoma Ag
7.12. Kinestica
7.13. Saebo
7.14. Neurostyle Pte Ltd
7.15. Ekso Bionics Holdings Inc

8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis

List of Tables
Table 1 Asia-Pacific Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)
Table 2 Asia-Pacific Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 3 Asia-Pacific Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 4 Asia-Pacific Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 5 Asia-Pacific Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)

List of Figures
Figure 1 Asia-Pacific Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 2 Supply Chain Outlook for Neurorehabilitation Device Market
Figure 3 Etymology of Neurorehabilitation Device Market
Figure 4 Asia-Pacific Neurorehabilitation Device Market, by Neuro-Robotic System, 2019-2028 (In $ Million)
Figure 5 Asia-Pacific Neurorehabilitation Device Market, by Brain-Computer Interface, 2019-2028 (In $ Million)
Figure 6 Asia-Pacific Neurorehabilitation Device Market, by Wearable Device, 2019-2028 (In $ Million)
Figure 7 Asia-Pacific Neurorehabilitation Device Market, by Non-Invasive Stimulator, 2019-2028 (In $ Million)
Figure 8 Asia-Pacific Neurorehabilitation Device Market, by Other Products, 2019-2028 (In $ Million)
Figure 9 Asia-Pacific Neurorehabilitation Device Market, by Stroke, 2019-2028 (In $ Million)
Figure 10 Asia-Pacific Neurorehabilitation Device Market, by Cerebral Palsy, 2019-2028 (In $ Million)
Figure 11 Asia-Pacific Neurorehabilitation Device Market, by Parkinson's Disease, 2019-2028 (In $ Million)
Figure 12 Asia-Pacific Neurorehabilitation Device Market, by Multiple Sclerosis, 2019-2028 (In $ Million)
Figure 13 Asia-Pacific Neurorehabilitation Device Market, by Other Applications, 2019-2028 (In $ Million)
Figure 14 Asia-Pacific Neurorehabilitation Device Market, by Hospital/Clinic, 2019-2028 (In $ Million)
Figure 15 Asia-Pacific Neurorehabilitation Device Market, by Research Institute, 2019-2028 (In $ Million)
Figure 16 Asia-Pacific Neurorehabilitation Device Market, by Cognitive Care Center, 2019-2028 (In $ Million)
Figure 17 Asia-Pacific Neurorehabilitation Device Market, by Other End-User, 2019-2028 (In $ Million)
Figure 18 China Neuro Rehabilitation Device Market 2019-2028 (In $ Million)
Figure 19 Japan Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 20 Australia & New Zealand Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 21 India Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 22 South Korea Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 23 Asean Countries Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 24 Rest of APAC Neurorehabilitation Device Market 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown
3 of 4
  • Bionik Laboratories Corp
  • Tyromotion Gmbh
  • Bioxtreme
  • Ectron Limited
  • Kinova
  • Abbott Laboratories
  • Biometrics Ltd
  • Reha Technology Ag
  • Medtronic Inc
  • Helius Medical Technologies
  • Hokoma Ag
  • Kinestica
  • Saebo
  • Neurostyle Pte Ltd
  • Ekso Bionics Holdings Inc
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll